Through the deal, dubbed the Spine Precision Partnership, the companies will look to jointly advance their proprietary technologies, looking to improve operating room workflow efficiency and the delivery of minimally disruptive spinal technologies, San Diego-based NuVasive said.
The first step in the partnership will be the integration of NuVasive’s Pulse surgical automation platform with Siemens Healthineers Cios Spin mobile 3D imaging platform designed for intra-operative quality assurance, the companies said.
“Currently, a number of hospitals and healthcare systems treat patients undergoing spine surgery through often cost-intensive, intra-operative CT scans with a general navigation system with limited utilization in spine surgery cases. The combination of NuVasive’s Pulse system and the Siemens Healthineers’ next-generation advanced imaging technology provides a compelling offering for hospitals and surgeons who require a scalable, cost-efficient technology that maximizes OR workflow efficiency and significantly improves visualization for spine surgery. We firmly believe that this combined offering will enable advanced clinical benefits driving superior patient outcomes, delivered through greatly improved visualization of the anatomy promoting successful anatomical access and spinal implant placement,” NuVasive chair & CEO Gregory Lucier said in a prepared statement.
“We at Siemens Healthineers are excited to work with NuVasive to develop intra-operative 3D-imaging and navigation tools for our advanced imaging systems that empower spine surgeons and neurosurgeons to be more precise, faster and cost efficient in the operating room. Increased workflow efficiency, better image quality, as well as predictable and reproducible results, will transform care delivery and set a new standard in spine surgery,” Siemens Healthineers surgery head Peter Seitz said in a press release.
Late last month, NuVasive said that it won FDA 510(k) clearance for its Pulse spinal surgical automation platform.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.